Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

[Mechanisms of carbapenems resistance in acinetobacter and progress of treatment].

Zhang W, Liu KZ.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Sep;39(5):542-7. Review. Chinese.

PMID:
20936732
2.

OXA (beta)-lactamases in Acinetobacter: the story so far.

Brown S, Amyes S.

J Antimicrob Chemother. 2006 Jan;57(1):1-3. Epub 2005 Dec 6. Review.

PMID:
16332731
3.

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Poirel L, Nordmann P.

Clin Microbiol Infect. 2006 Sep;12(9):826-36. Review.

4.

Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.

Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez MA, de Alba PD, Infante-Martínez V, Pascual A.

Int J Antimicrob Agents. 2012 Jan;39(1):93-4. doi: 10.1016/j.ijantimicag.2011.07.017. Epub 2011 Oct 7. No abstract available.

PMID:
21982835
5.

Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.

Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P.

J Clin Microbiol. 2005 Sep;43(9):4885-8.

6.

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.

Lim TP, Tan TY, Lee W, Sasikala S, Tan TT, Hsu LY, Kwa AL.

J Antibiot (Tokyo). 2009 Dec;62(12):675-9. doi: 10.1038/ja.2009.99. Epub 2009 Oct 30.

PMID:
19876075
7.
8.

In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.

Tong W, Wang R, Chai D, Li Z, Pei F.

Int J Antimicrob Agents. 2006 Nov;28(5):454-6. Epub 2006 Sep 20.

PMID:
16987639
9.

Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.

Int J Antimicrob Agents. 2005 Jan;25(1):57-61.

PMID:
15620827
10.

Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp.

Mostachio AK, van der Heidjen I, Rossi F, Levin AS, Costa SF.

J Med Microbiol. 2009 Nov;58(Pt 11):1522-4. doi: 10.1099/jmm.0.011080-0. Epub 2009 Jul 2. No abstract available.

PMID:
19574410
11.

The impact of carbapenemases on antimicrobial development and therapy.

Livermore DM.

Curr Opin Investig Drugs. 2002 Feb;3(2):218-24. Review.

PMID:
12020049
12.

Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Marti S, Sánchez-Céspedes J, Blasco MD, Ruiz M, Espinal P, Alba V, Fernández-Cuenca F, Pascual A, Vila J.

Antimicrob Agents Chemother. 2008 Aug;52(8):2955-8. doi: 10.1128/AAC.00072-08. Epub 2008 May 27.

13.

Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.

Zavascki AP, Soares FC, Superti SV, Silbert S, Silva FM, Barth AL.

Int J Antimicrob Agents. 2007 Aug;30(2):187-9. Epub 2007 Apr 23. No abstract available.

PMID:
17452093
14.

AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates.

Kim DH, Choi JY, Jung SI, Thamlikitkul V, Song JH, Ko KS.

Antimicrob Agents Chemother. 2012 Aug;56(8):4548-9. doi: 10.1128/AAC.00923-12. Epub 2012 Jun 11.

15.

Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.

Gupta V.

Expert Opin Investig Drugs. 2008 Feb;17(2):131-43. doi: 10.1517/13543784.17.2.131. Review.

PMID:
18230049
16.
17.

[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].

Eser OK, Ergin A, Hasçelik G.

Mikrobiyol Bul. 2009 Jul;43(3):383-90. Turkish.

PMID:
19795613
18.

Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3.

Boo TW, Walsh F, Crowley B.

J Med Microbiol. 2009 Feb;58(Pt 2):209-16. doi: 10.1099/jmm.0.004911-0.

PMID:
19141738
19.

Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.

Espinal P, Roca I, Vila J.

Future Microbiol. 2011 May;6(5):495-511. doi: 10.2217/fmb.11.30.

PMID:
21585259
20.

Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

López-Hernández S, Alarcón T, López-Brea M.

Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):282-5.

PMID:
9707314

Supplemental Content

Support Center